Kim Q. Do: Antioxidants specifically targeted at mitochondria: A novel therapeutic approach to schizophrenia
Brain Medicine · 2024
DOI: 10.61373/bm024k.0025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Medicine, 2024. Verfasst von Kim Q. Do. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kim Q. Do was appointed senior lecturer at the University of Lausanne (CH) in 2000. Over the years, she became an associate professor of translational psychiatry in 2011 and attained the position of full professor in 2017. In 1999, she established the Unit for Research in Schizophrenia at the Center for Psychiatric Neuroscience within the Department of Psychiatry at Lausanne University Hospital. She served as the head of this unit from 1999 until 2022. Additionally, she was the Center for Psychiatric Neuroscience director from 2013 to 2019. She holds visiting professor positions at Harvard Medical School in Boston, USA, the Institute of Psychiatry, Psychology & Neuroscience at King's College London, UK, and the Swiss Federal Institute of Technology Lausanne (EPFL). Professor Do graciously consented to participate in the Genomic Press interview, offering insights into her unique personal and professional journeys.
Zitieren
APA
Do, K. Q. (2024). Kim Q. Do: Antioxidants specifically targeted at mitochondria: A novel therapeutic approach to schizophrenia. Brain Medicine. https://doi.org/10.61373/bm024k.0025
Vancouver
Do KQ. Kim Q. Do: Antioxidants specifically targeted at mitochondria: A novel therapeutic approach to schizophrenia. Brain Medicine. 2024. doi:10.61373/bm024k.0025
BibTeX
@article{Do2024,
author = {Do, Kim Q.},
title = {Kim Q. Do: Antioxidants specifically targeted at mitochondria: A novel therapeutic approach to schizophrenia},
journal = {Brain Medicine},
year = {2024},
doi = {10.61373/bm024k.0025}
}
EUVIMED